je.st
news
Tag: vaccine
The Latest: US starts research into possible Zika vaccine
2016-01-27 03:38:11| Biotech - Topix.net
The latest on the fight against the Zika virus that health officials suspect is linked to a wave of birth defects in Brazil. : The U.S. government is beginning research into a possible vaccine for the mosquito-borne Zika virus that is suspected of causing an unusual birth defect as it spreads in Latin America.
Tags: research
latest
starts
vaccine
GeneOne Life Science And Inovio Pharmaceuticals To Collaborate On Zika Virus Vaccine Development
2016-01-25 04:31:25| drugdiscoveryonline News Articles
GeneOne Life Science (KSE:011000) today announced the initiation of a collaborative research program with Inovio Pharmaceuticals (NASDAQ:INO) to test and advance a DNA-based vaccine for preventing and treating the emerging and virulent Zika virus infection.
Tags: life
development
science
virus
Meningitis B vaccine shortage halts new private jabs
2016-01-22 15:48:36| Biotech - Topix.net
Parents hoping to have their children vaccinated privately against meningitis B have been told there is a shortage of vaccine. But private clinics in the UK have been advising parents that they cannot start any new courses of the vaccine.
Tags: private
shortage
vaccine
meningitis
Global Vaccine promises $5 million to develop Ebola vaccine
2016-01-20 12:57:46| Biotech - Topix.net
The global vaccine alliance GAVI says it will donate $5 million toward developing the leading Ebola vaccine, hoping that it will be approved by a regulator by the end of 2017. If the vaccine is given the green light, GAVI says it will then create a stockpile to help stamp out future outbreaks of the lethal disease.
Tags: global
million
develop
promises
World Health Organization to Review Mercks Investigational Ebola Vaccine for Emergency Use Assessment and Listing
2015-12-23 14:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the application for Emergency Use Assessment and Listing (EUAL) for the companys investigational Ebola Zaire vaccine, V920 (rVSVG-ZEBOV-GP, live attenuated), has been accepted for review by the World Health Organization (WHO). Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Skip Irvine, 215-652-6059orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: world
health
review
listing
Sites : [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] next »